Innovative treatment approaches, including antibody-drug conjugates, biomarker-based therapies, and targeted therapies designed to overcome treatment resistance are revolutionizing care across breast cancer subtypes. Are you prepared to individualize care based on the latest evidence and guideline recommendations? Join us for Part 7 of our Breast Cancer Hot Topics as our expert breast oncologists present challenging patient scenarios. Put your skills to the test and compete to be at the top of the leaderboard in this interactive session featuring: Expert strategies for effective integration of molecular testing and evaluation of relevant biomarkers for clinical decision-making Effective prevention and management of treatment-related adverse events A special Clinician Spotlight sharing real-world insights and practical approaches to integrate novel therapies into practice from a recent quality improvement (QI) initiative A compelling patient vignette to demonstrate the real-world application of personalized treatment strategies.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 360 Park Avenue South
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedOct 24, 2025
-
Last day to claim creditOct 24, 2026 2 weeks left
-
PRIME Education, Inc. (PRIME®) Evolving Treatment Strategies in ES-SCLC: From Emerging Evidence to Patient Care
-
PRIME Education, Inc. (PRIME®) Ascent to Evidence-Based ADC Integration: Real-World Strategies to Shape the Destiny of mBC Care
-
PRIME Education, Inc. (PRIME®) Expert Perspectives on Integrating Novel Therapies for ES-SCLC Into Practice
-
Global Learning Collaborative Treatment Decisions That Matter: A Case-Based Discussion in Advanced Ovarian Cancer
-
Physicians’ Education Resource Community Practice Connections(TM): How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer
-
EfficientCME, CME Outfitters, LLC From Data to Decisions: An Integrated CME Activity Designed to Assess and Compare the Practice Patterns of Specialists and General Oncologists Related to the Management of HER2-Negative Metastatic Breast Cancer
